Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response

Background and aimsGiven hepatitis B virus (HBV)-related hepatocellular carcinoma (HBV-HCC) exhibits unique gut microbiota characteristics and a significant immunosuppressive tumor microenvironment. Thus, a better understanding of the correlation between gut microbiota and the immunosuppressive resp...

Full description

Bibliographic Details
Main Authors: Fengna Yan, Qun Zhang, Ke Shi, Yi Zhang, Bingbing Zhu, Yufei Bi, Xianbo Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2023.1152987/full
_version_ 1797835607891771392
author Fengna Yan
Qun Zhang
Ke Shi
Yi Zhang
Bingbing Zhu
Yufei Bi
Xianbo Wang
author_facet Fengna Yan
Qun Zhang
Ke Shi
Yi Zhang
Bingbing Zhu
Yufei Bi
Xianbo Wang
author_sort Fengna Yan
collection DOAJ
description Background and aimsGiven hepatitis B virus (HBV)-related hepatocellular carcinoma (HBV-HCC) exhibits unique gut microbiota characteristics and a significant immunosuppressive tumor microenvironment. Thus, a better understanding of the correlation between gut microbiota and the immunosuppressive response may help predict occurrence and prognosis of HBV-HCC.MethodsHere, in a cohort of ninety adults (healthy control n=30, HBV-cirrhosis n=30, HBV-HCC n=30) with clinical data, fecal 16S rRNA gene sequencing, matched peripheral blood immune response with flow cytometry analysis. Correlation between the gut microbiome of significantly different in HBV-HCC patients and clinical parameters as well as the peripheral immune response was assessed.ResultsWe found that community structures and diversity of the gut microbiota in HBV-CLD patients become more unbalanced. Differential microbiota analysis that p:Acidobacteriota, p:Proteobacteria, p:Campilobacterota, f:Streptococcaceae, g:Klebsiella associated with inflammation were enriched. The beneficial bacteria of f:Clostridia UCG−014, f:Oscillospiraceae, f:_Rikenellaceae, g:_Barnesiella, g:Prevotella, g:Agathobacter were decreased. Functional analysis of gut microbiota revealed that lipopolysaccharide biosynthesis, lipid metabolism, butanoate metabolism were significantly elevated in HBV-CLD patients. Spearman’s correlation analysis showed that Muribaculaceae, Akkermaniacaeae, [Eubacterium]_coprostanoligenes_group, RF39, Tannerellaceae have positive correlation with CD3+T, CD4+T and CD8+T cell counts while negatively correlated with liver dysfunction. Furthermore, paired peripheral blood showed a decreased proportion of CD3+T, CD4+T and CD8+T cells, while an increased T (Treg) cells. The immunosuppressive response of programmed cell death 1 (PD-1), cytotoxic T-lymphocyte antigen 4 (CTLA-4), immune receptor tyrosine based inhibitor motor (ITIM) domain (TIGIT), T-cell immune domain, and multiple domain 3 (TIM-3) of CD8+T cells were higher in HBV-HCC patients. They were positively correlated with harmful bacteria, such as Actinobaciota, Myxococota, Streptococcaceae and Eubacterium coprostanoligenes.ConclusionsOur study indicated that gut beneficial bacteria, mainly Firmicutes and Bacteroides appeared dysbiosis in HBV-CLD patients. They have negative regulation of liver dysfunction and T cell immune response. It provides potential avenues for microbiome-based prevention and intervention for anti-tumor immune effects of HBV-CLD.
first_indexed 2024-04-09T14:56:19Z
format Article
id doaj.art-5774a73309bf4d6c9a88f1d54d27b786
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-04-09T14:56:19Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-5774a73309bf4d6c9a88f1d54d27b7862023-05-02T05:05:00ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882023-05-011310.3389/fcimb.2023.11529871152987Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune responseFengna YanQun ZhangKe ShiYi ZhangBingbing ZhuYufei BiXianbo WangBackground and aimsGiven hepatitis B virus (HBV)-related hepatocellular carcinoma (HBV-HCC) exhibits unique gut microbiota characteristics and a significant immunosuppressive tumor microenvironment. Thus, a better understanding of the correlation between gut microbiota and the immunosuppressive response may help predict occurrence and prognosis of HBV-HCC.MethodsHere, in a cohort of ninety adults (healthy control n=30, HBV-cirrhosis n=30, HBV-HCC n=30) with clinical data, fecal 16S rRNA gene sequencing, matched peripheral blood immune response with flow cytometry analysis. Correlation between the gut microbiome of significantly different in HBV-HCC patients and clinical parameters as well as the peripheral immune response was assessed.ResultsWe found that community structures and diversity of the gut microbiota in HBV-CLD patients become more unbalanced. Differential microbiota analysis that p:Acidobacteriota, p:Proteobacteria, p:Campilobacterota, f:Streptococcaceae, g:Klebsiella associated with inflammation were enriched. The beneficial bacteria of f:Clostridia UCG−014, f:Oscillospiraceae, f:_Rikenellaceae, g:_Barnesiella, g:Prevotella, g:Agathobacter were decreased. Functional analysis of gut microbiota revealed that lipopolysaccharide biosynthesis, lipid metabolism, butanoate metabolism were significantly elevated in HBV-CLD patients. Spearman’s correlation analysis showed that Muribaculaceae, Akkermaniacaeae, [Eubacterium]_coprostanoligenes_group, RF39, Tannerellaceae have positive correlation with CD3+T, CD4+T and CD8+T cell counts while negatively correlated with liver dysfunction. Furthermore, paired peripheral blood showed a decreased proportion of CD3+T, CD4+T and CD8+T cells, while an increased T (Treg) cells. The immunosuppressive response of programmed cell death 1 (PD-1), cytotoxic T-lymphocyte antigen 4 (CTLA-4), immune receptor tyrosine based inhibitor motor (ITIM) domain (TIGIT), T-cell immune domain, and multiple domain 3 (TIM-3) of CD8+T cells were higher in HBV-HCC patients. They were positively correlated with harmful bacteria, such as Actinobaciota, Myxococota, Streptococcaceae and Eubacterium coprostanoligenes.ConclusionsOur study indicated that gut beneficial bacteria, mainly Firmicutes and Bacteroides appeared dysbiosis in HBV-CLD patients. They have negative regulation of liver dysfunction and T cell immune response. It provides potential avenues for microbiome-based prevention and intervention for anti-tumor immune effects of HBV-CLD.https://www.frontiersin.org/articles/10.3389/fcimb.2023.1152987/fullgut microbiomeliver diseaseT cell immunosuppressionhepatocellular carcinomaperipheral immune response
spellingShingle Fengna Yan
Qun Zhang
Ke Shi
Yi Zhang
Bingbing Zhu
Yufei Bi
Xianbo Wang
Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response
Frontiers in Cellular and Infection Microbiology
gut microbiome
liver disease
T cell immunosuppression
hepatocellular carcinoma
peripheral immune response
title Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response
title_full Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response
title_fullStr Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response
title_full_unstemmed Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response
title_short Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response
title_sort gut microbiota dysbiosis with hepatitis b virus liver disease and association with immune response
topic gut microbiome
liver disease
T cell immunosuppression
hepatocellular carcinoma
peripheral immune response
url https://www.frontiersin.org/articles/10.3389/fcimb.2023.1152987/full
work_keys_str_mv AT fengnayan gutmicrobiotadysbiosiswithhepatitisbvirusliverdiseaseandassociationwithimmuneresponse
AT qunzhang gutmicrobiotadysbiosiswithhepatitisbvirusliverdiseaseandassociationwithimmuneresponse
AT keshi gutmicrobiotadysbiosiswithhepatitisbvirusliverdiseaseandassociationwithimmuneresponse
AT yizhang gutmicrobiotadysbiosiswithhepatitisbvirusliverdiseaseandassociationwithimmuneresponse
AT bingbingzhu gutmicrobiotadysbiosiswithhepatitisbvirusliverdiseaseandassociationwithimmuneresponse
AT yufeibi gutmicrobiotadysbiosiswithhepatitisbvirusliverdiseaseandassociationwithimmuneresponse
AT xianbowang gutmicrobiotadysbiosiswithhepatitisbvirusliverdiseaseandassociationwithimmuneresponse